Komori
Linical (2183) · InitiativeAdvancedLatest Earnings (2026-08-14): "Restated"

Improving Profitability Through Lean Business Operations

First written in FY2023-Q1. 6 of 10 entries say "Restated". Latest entry: 2026-08-14.

10entries
5years
3from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2023-Q1 – FY2026-H12022: 220222023: 220232024: 120242025: 120252026: 42026
Same theme, other companies
Improving Profitability by Selecting and Organizing Low-Margin Projects and Managing Costs Across the CompanyA theme 401 companies write about · 3 as a headwind · 427 as a tailwind

40 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 188 companies compared. The sentences above are computed from all 188.Comparing 200 of the theme's 430 threads.
Full recordFilings, disclosures and news, newest first
  1. 2026-08-14RestatedEarnings

    「We will continue working to improve performance by implementing measures to raise staff utilization and strictly managing expenses.」

    日本事業について、人員稼働率向上と経費管理による業績改善方針が再確認された。
  2. FY2026AdvancedAnnual report

    「Although we have worked to lower the break-even point, including by reducing headcount in regions where there is no prospect of improving utilization, we will continue working to improve performance by implementing measures to raise staff utilization and strictly managing expenses.」

    The disclosure specifies measures under lean operations, including raising staff utilization, managing expenses, and lowering the break-even point by reducing headcount in regions where there is no prospect of improving utilization.
  3. FY2026-H1RestatedAnnual report

    「We will continue working to improve performance by implementing measures to raise staff utilization and strictly managing expenses.」

    For the Japanese business, the Company reconfirmed its operating policy of improving performance by implementing measures to raise staff utilization and strictly managing expenses.
  4. FY2025-H1RestatedAnnual report

    「We will also implement measures to improve staff utilization and conduct a thorough review of selling, general and administrative expenses in an effort to improve performance.」

    For the Japanese business, the Company reconfirmed its operating policy of improving performance through measures to raise staff utilization and a review of selling, general and administrative expenses.
  5. FY2024-Q1RestatedAnnual report

    「In terms of profit, operating profit amounted to ¥112 million, compared with an operating loss of ¥26 million in the same period of the previous year, as the United States and South Korea made strong starts and generated higher profit, while Japan also secured profit at a level comparable to the previous fiscal year.」

    In addition to higher profit in the United States and South Korea, Japan secured profit at a level comparable to the previous fiscal year through expense controls and other measures. The disclosure describes the benefits of cost management consistent with lean operations.
  6. FY2023-Q3RestatedAnnual report

    「The large-scale trial mentioned above has progressed generally smoothly since starting in the latter half of July. Utilization rates have remained high due also to the commencement of other new projects and increased hours resulting from contract amendments. We will continue to rigorously manage progress on orders and strictly control labor costs and expenses according to the orders received, while working to improve profit margins.」

    Based on progress in the large-scale trial and high staff utilization rates, the Company continues efforts to manage progress on orders, strictly control labor costs and expenses, and improve profit margins.
  7. FY2023-Q2RestatedAnnual report

    「We will continue working to accelerate revenue recognition through rigorous progress management for orders, conclude contracts and commence operations promptly for projects that have received informal approval, and increase revenue by winning new projects currently under negotiation, while strictly controlling labor costs and expenses according to the orders received.」

    The Company reconfirmed specific measures for lean operations: progress management for orders, early contracting and commencement of projects that have received informal approval, acquisition of new projects, and management of labor costs and expenses in line with orders received.
  8. FY2023-Q1First statedAnnual report

    「In terms of profit, the Company made a strong start, helped by revenue growth in Japan and lean operations that have continued since the previous fiscal year.」

    Lean operations, which have continued since the previous fiscal year, were recorded for the first time as an independent theme and as a profit factor alongside revenue growth. No specific measures or numerical targets were disclosed.
Moved together

"Customer Focus on Major Pharmaceutical Companies" moved the same way as this thread, in the same document, in 3 of its 10 moves.

33222★12345
  1. ★This thread
  2. 1Customer Focus on Major Pharmaceutical Companies3×
  3. 2Global structure to support international joint clinical trials3×
  4. 3Expanding the customer base through drug discovery support services2×
  5. 4One-stop Services from Drug Discovery through Post-marketing2×
  6. 5Adaptation to Digital Technologies, Including Decentralized Clinical Trials2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Linical yet. It last moved in the Earnings of 2026-08-14: "Restated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Improving Profitability Through Lean Business Operations | Linical Co.,Ltd. (2183) | Komori